3D and 3Rs Revenue
Biotechnology Research • 
Cambridge, England, United Kingdom • 1-10 Employees
$
3D and 3Rs revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at 3D and 3Rs
Pelin Candarlioglu Deacon
Director
Company overview
| Headquarters | Cambridge, England, United Kingdom |
| NAICS | 541714 |
| Keywords | Consultancy, Safety, Oncology, Preclinical Research, Cell Therapy, Drug Discovery And Development, Efficacy, Organ On Chip, Disease Modelling, Complex In Vitro Models |
| Founded | 2023 |
| Employees | 1-10 |
About 3D and 3Rs
We provide expert support, advice and management of adopting non-animal models (NAMs) to organizations anywhere in the world. From start-ups and academic consortiums to large organizations, covering both technology development and also application in early discovery or late development stages of pharmaceutical applications.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
3D and 3Rs has never raised funding before.
United States
Canada
Spain
Frequently asked questions
3D and 3Rs is located in Cambridge, England, GB.
3D and 3Rs generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
3D and 3Rs has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
3D and 3Rs was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
3D and 3Rs has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
